SPL 0.00% 9.2¢ starpharma holdings limited

Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,235 Posts.
    lightbulb Created with Sketch. 584
    i would also ask, in ph3 trial, assume a deal and financed, the DeP be used as a first line application NOT as a last resort, ie early stage!!??

    if i was with one of those horrible cancers i would want to try DeP early stage, while results in these trails are good, still the % of those not surviving and turmour shrinage is not a great outcome % for me, so better odds me thinks in early stage use
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.